Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides

European Journal of Immunology

Volumn 30, Issue 6, 2000, Pages 1676-1682

  Kern, Florian ^a   Faulhaber, Nicole ^a   Frommel, Claudia ^a   Khatamzas, Elham ^a   Prösen, Susanna ^a   Schönemann, Constanze ^a   Kretzschmar, Inès ^a   Volkmer Engert, Rudolf ^a   Volk, Hans Dieter ^a   Reinke, Petra ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Human cytomegalovirus; Immediate early 1protein; Peptide pool; pp65

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; IMMEDIATE EARLY PROTEIN; PEPTIDE; VIRUS PROTEIN;

ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS IMMUNITY;

AMINO ACID SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HLA-A1 ANTIGEN; HLA-A2 ANTIGEN; HLA-B7 ANTIGEN; HLA-B8 ANTIGEN; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERFERON TYPE II; MOLECULAR SEQUENCE DATA; PEPTIDES; PHOSPHOPROTEINS; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

EID: 0034093051     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200006)30:6<1676::AID-IMMU1676>3.0.CO;2-V     Document Type: Article

References (22)

1. Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J. and Davis, M. M., Phenotypic analysis of antigen-specific T lymphocytes [published erratum appears in Science 1998. 280: 1821]. Science 1996. 274:94-96.
2. Kern, F., Surel, I. P., Brock, C., Freistedt, B., Radtke, H., Scheffold, A., Blasczyk, R., Reinke, P., Schneider-Mergener, J., Radbruch, A., Waiden, P. and Volk, H. D., T-cell epitope mapping by flow cytometry. Nat. Med. 1998. 4: 975-978.
3. Kern, F., Khatamzas, E., Surel, I., Fromme!, C., Reinke, P., Waldrop, S. L., Picker, L, J. and Volk, H. D., Distribution of human CMV-specific memory T cells among the CD8(pos.) subsets defined by CD57, CD27, and CD45 isoforms. Eur. J. Immunol. 1999.29:2908-2915.
4. Tan, L. C., Gudgeon, N., Annels, N. E., Hansasuta, P., O'Collaghan, C. A., Rowland-Jones, S., McMichael, A. J., Rickinson, A. B. and Callan, M. F., A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J. Immunol. 1999. 162: 1827-1835.
5. Kern, F., Surel, I. P., Faulhaber, N., Frommel, C., Schneider Mergener, J., Schonemann, C., Reinke, P. and Volk, H. D., Target structures of the CD8{+)-T-cell responses to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. J. Virol. 1999. 73: 8179-8184.
6. Waldrop, S. L., Pitcher, C. J., Peterson, D. M., Maino, V. C. and Picker, L. J., Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J. Clin. Invest. 1997. 99:1739-1750.
7. Rammensee, H. G., Bachmann, J. and Stefanovic, S. (Eds) MHC Ligands and binding motifs. Landes Bioscience, Georgetown, Texas 1997.
8. Lo, C. Y., Ho, K. N., Yuen, K. Y., Lui, S. L., Li, F. K., Chan, T. M., Lo, W. K. and Cheng, I. K., Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay. Clin. Transplant. 1997. 11:286-293.
9. Brennan, D. C., Garlock, K. A., Singer, G. G., Schnitzler, M. A., Lippmann, B. J., Buller, R. S., Gaudreault-Keener, M., Lowed, J. A., Shenoy, S., Howard, T. K. and Storch, G. A., Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients. Transplantation 1997.64:1843-1846.
10. Sherman, L. A., Burke, T. A. and Biggs, J. A., Extracellular processing of peptide antigens that bind class I major histocompatibility molecules. J. Exp. Med. 1992.175:1221-1226.
11. Kozlowski, S., Corr, M., Takeshita, T., Boyd, L. F., Pendleton, C. 0., Germain, R. N., Berzofsky, J. A. and Margulies, D. H., Serum angiotension-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules. J. Exp. Med. 1992.175:1417-1422.
12. Kozlowski, S., Corr, M., Shirai, M., Boyd, L. F., Pendleton, C. D., Berzofsky, J. A. and Margulies, D. H., Multiple pathways are involved in the extracellular processing of MHO class 1-restricted peptides. J. Immunol. 1993.151: 4033-4044.
13. Eberl, G., Renggli, J., Men, Y., Roggero, M. A., Lopez, J. A. and Corradin, G., Extracellular processing and presentation of a 69-mer synthetic polypeptide to MHC class l-restricted T cells. Mol. Immunol. 1999. 36:103-112.
14. Fields, G. B. and Noble, R. L., Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 1990. 35: 161-214.
15. Udaka, K., Wiesmüller, K. H., Kienle, S., Feiertag, S., Jung, G. and Waiden, P., Random peptide libraries as tools in basic and applied immunology. In Jung, G. (Ed.), Combinatorial Peptide and Nonpeptide Libraries. VCH Verlagsgesellschaft mbH, Weinheim 1996, pp 349-362.
16. Reusser, P., Cathomas, G., Attenhofer, R., Tamm, M. and Thiel, G., Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load. J. Infect. Dis. 1999. 180: 247-253.
17. Wills, M. R., Carmichael, A. J., Mynard, K., Jin, X., Weekes, M. P., Plachter, B. and Sissons, J. G., The human cytotoxic T-lymphocytes (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J. Wol. 1996. 70: 7569-7579.
18. Brennan, D. C., Garlock, K. A., Lippmann, B. A., Buller, R. S., Gaudrealt-Keener, M., Lowed, J. A., Miller, S. B., Shenoy, S., Howard, T. K. and Storch, G. A., Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred theapy. J. Am. Soc. Nephrol. 1997.8:118-125.
19. Rollag, H., Sagedal, S., Holter, E., Degré, M., Ariansen, S. and Nordal, K. P., Diagnosis of cytomegalovirus infection in kidney transplant recipients by a quantitative RNA-DNA hybrid capture assay for cytomegalovirus DNA in leukocytes. Eur. J. Clin. Microbiol. Infect. Dis. 1998.17:124-127.
20. Roberts, T. C., Brennan, D. C., Buller, R. S., Gaudreault-Keener, M., Schnitzler, M. A., Sternhell, K. E., Garlock, K. A., Singer, G. G. and Storch, G. A., Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients. J. Infect. Dis. 1998.178: 626-635.
21. Plotkin, S. A., Vaccination against cytomegalovirus, the changeling demon. Pediatr. Infect. Dis. J. 1999.18:313-325; quiz 326.
22. Evans, T. G., Keefer, M. C., Weinhold, K. J., Wolff, M., Montefiori, D., Gorse, G. J., Graham, B. S., McElrath, M. J., Clements-Mann, M. L, Mulligan, M. J., Fast, P., Walker, M. C., Excler, J. L., Duliege, A. M. and Tartaglia, J., A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers. J. Infect. Dis. 1999.180: 290-298.